These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18166271)

  • 41. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats.
    Krowicki ZK; Kapusta DR
    J Pharmacol Exp Ther; 2006 Apr; 317(1):446-53. PubMed ID: 16407463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
    Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
    Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats.
    Shane R; Lazar DA; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 2001 Jul; 907(1-2):109-16. PubMed ID: 11430891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nociceptin/orphanin FQ (N/OFQ) inhibits excitatory and inhibitory synaptic signaling in the suprachiasmatic nucleus (SCN).
    Gompf HS; Moldavan MG; Irwin RP; Allen CN
    Neuroscience; 2005; 132(4):955-65. PubMed ID: 15857701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.
    Dono LM; Currie PJ
    Neuropharmacology; 2012 Jan; 62(1):192-9. PubMed ID: 21736884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze.
    Zangrossi H; Viana MB; Graeff FG
    Eur J Pharmacol; 1999 Mar; 369(3):267-70. PubMed ID: 10225362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug.
    Hayashi S; Hirao A; Imai A; Nakamura H; Murata Y; Ohashi K; Nakata E
    J Med Chem; 2009 Feb; 52(3):610-25. PubMed ID: 19125610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.
    Jenck F; Moreau JL; Martin JR; Kilpatrick GJ; Reinscheid RK; Monsma FJ; Nothacker HP; Civelli O
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14854-8. PubMed ID: 9405703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala.
    László K; Kovács A; Zagoracz O; Ollmann T; Péczely L; Kertes E; Lacy DG; Lénárd L
    Behav Brain Res; 2016 Jan; 296():279-285. PubMed ID: 26386304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice.
    Gavioli EC; Rizzi A; Marzola G; Zucchini S; Regoli D; Calo' G
    Peptides; 2007 Jun; 28(6):1229-39. PubMed ID: 17499882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
    Jenck F; Wichmann J; Dautzenberg FM; Moreau JL; Ouagazzal AM; Martin JR; Lundstrom K; Cesura AM; Poli SM; Roever S; Kolczewski S; Adam G; Kilpatrick G
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4938-43. PubMed ID: 10758169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation.
    Mallimo EM; Kusnecov AW
    Front Cell Neurosci; 2013 Oct; 7():173. PubMed ID: 24155687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The elevated T-maze as an experimental model of anxiety.
    Graeff FG; Netto CF; Zangrossi H
    Neurosci Biobehav Rev; 1998; 23(2):237-46. PubMed ID: 9884116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala.
    Bild W; Ciobica A
    J Affect Disord; 2013 Feb; 145(2):165-71. PubMed ID: 22868060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitigation of adverse behavioral impact from predator exposure by the nociceptin/orphanin FQ peptide antagonist J-113397 in rats.
    Genovese RF; Dobre S
    Behav Pharmacol; 2017 Oct; 28(7):521-530. PubMed ID: 28704271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Orphanin FQ / Nociceptin receptor as a novel drug target in psychiatric disorders.
    Reinscheid RK
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):219-24. PubMed ID: 16611094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice.
    Köster A; Montkowski A; Schulz S; Stübe EM; Knaudt K; Jenck F; Moreau JL; Nothacker HP; Civelli O; Reinscheid RK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10444-9. PubMed ID: 10468628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.
    Silva AI; Holanda VAD; Azevedo Neto JG; Silva Junior ED; Soares-Rachetti VP; Calo G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2020 Jun; 237(6):1633-1642. PubMed ID: 32095915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent.
    Hirao A; Imai A; Sugie Y; Yamada Y; Hayashi S; Toide K
    J Pharmacol Sci; 2008 Mar; 106(3):361-8. PubMed ID: 18319566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.